PL334558A1 - Cephalosporinic derivatives - Google Patents

Cephalosporinic derivatives

Info

Publication number
PL334558A1
PL334558A1 PL97334558A PL33455897A PL334558A1 PL 334558 A1 PL334558 A1 PL 334558A1 PL 97334558 A PL97334558 A PL 97334558A PL 33455897 A PL33455897 A PL 33455897A PL 334558 A1 PL334558 A1 PL 334558A1
Authority
PL
Poland
Prior art keywords
cephalosporinic
derivatives
cephalosporinic derivatives
Prior art date
Application number
PL97334558A
Other languages
English (en)
Inventor
Dane M Springer
Bing Y Luh
Andrea Stanley V D
Thomas W Hudyma
Oak K Kim
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of PL334558A1 publication Critical patent/PL334558A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL97334558A 1996-11-27 1997-11-21 Cephalosporinic derivatives PL334558A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3404696P 1996-11-27 1996-11-27

Publications (1)

Publication Number Publication Date
PL334558A1 true PL334558A1 (en) 2000-03-13

Family

ID=21873971

Family Applications (1)

Application Number Title Priority Date Filing Date
PL97334558A PL334558A1 (en) 1996-11-27 1997-11-21 Cephalosporinic derivatives

Country Status (17)

Country Link
EP (1) EP0966472A1 (US20020095090A1-20020718-M00002.png)
JP (1) JP2001506607A (US20020095090A1-20020718-M00002.png)
KR (1) KR20000057283A (US20020095090A1-20020718-M00002.png)
CN (1) CN1238775A (US20020095090A1-20020718-M00002.png)
AR (1) AR010650A1 (US20020095090A1-20020718-M00002.png)
AU (1) AU734948B2 (US20020095090A1-20020718-M00002.png)
BR (1) BR9713350A (US20020095090A1-20020718-M00002.png)
CA (1) CA2272717A1 (US20020095090A1-20020718-M00002.png)
CZ (1) CZ185399A3 (US20020095090A1-20020718-M00002.png)
HU (1) HUP9903621A3 (US20020095090A1-20020718-M00002.png)
IL (1) IL129437A0 (US20020095090A1-20020718-M00002.png)
NO (1) NO992526L (US20020095090A1-20020718-M00002.png)
NZ (1) NZ335892A (US20020095090A1-20020718-M00002.png)
PL (1) PL334558A1 (US20020095090A1-20020718-M00002.png)
TW (1) TW414796B (US20020095090A1-20020718-M00002.png)
WO (1) WO1998023621A1 (US20020095090A1-20020718-M00002.png)
ZA (1) ZA9710662B (US20020095090A1-20020718-M00002.png)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265394B1 (en) * 1997-07-31 2001-07-24 Bristol-Myers Squibb Company Bis quaternary MRSA cephem derivatives
KR20020085180A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
KR20020085181A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
KR20020085178A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
KR20020085176A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
KR20030071311A (ko) * 2002-02-28 2003-09-03 주식회사 엘지생명과학 신규 세팔로스포린 화합물 및 그의 제조방법
KR20140034798A (ko) * 2011-05-18 2014-03-20 신젠타 파티서페이션즈 아게 아릴티오아세트아미드 유도체에 기반한 살곤충 화합물
CN105131018B (zh) * 2015-09-23 2017-12-26 浙江华方药业股份有限公司 一种头孢替唑酸的制备方法
CN114957056A (zh) * 2021-02-20 2022-08-30 帕潘纳(北京)科技有限公司 制备3-甲基-2-氯-4-甲基磺酰基苯甲酸甲酯及其中间体的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3345366A (en) * 1967-02-15 1967-10-03 American Cyanamid Co Substituted 7-acetylamino cephalosporanic acids
US4148997A (en) * 1977-11-07 1979-04-10 Yeda Research And Development Co., Ltd. 7-[Sulfomethyl)phenyl]acetamidocephalosporin derivatives
US5567698A (en) * 1995-02-15 1996-10-22 Bristol-Myers Squibb Company Pyridinium thiomethyl substituted chepholosporin derivatives
US5620969A (en) * 1995-04-25 1997-04-15 Bristol-Myers Squibb Company Cephalosporin derviatives
AU1278197A (en) * 1995-12-20 1997-07-14 Bristol-Myers Squibb Company Cephalosporin derivatives

Also Published As

Publication number Publication date
JP2001506607A (ja) 2001-05-22
IL129437A0 (en) 2000-02-17
CA2272717A1 (en) 1998-06-04
CN1238775A (zh) 1999-12-15
EP0966472A4 (US20020095090A1-20020718-M00002.png) 1999-12-29
AR010650A1 (es) 2000-06-28
BR9713350A (pt) 2000-01-25
AU5365298A (en) 1998-06-22
AU734948B2 (en) 2001-06-28
NO992526D0 (no) 1999-05-26
HUP9903621A3 (en) 2001-05-28
WO1998023621A1 (en) 1998-06-04
KR20000057283A (ko) 2000-09-15
NO992526L (no) 1999-05-26
CZ185399A3 (cs) 1999-08-11
TW414796B (en) 2000-12-11
HUP9903621A2 (hu) 2000-04-28
NZ335892A (en) 2001-07-27
EP0966472A1 (en) 1999-12-29
ZA9710662B (en) 1999-05-26

Similar Documents

Publication Publication Date Title
ZA972689B (en) 6-Phenylpyridyl-2-amine derivatives
HU9700358D0 (en) New oxazolidinon derivatives
AP9701156A0 (en) 6-phenylpyridyl-2-amine derivatives
EG24081A (en) 4-Substituted-9-deoxo-9a-aza-9a-homerythromycin derivatives
IL125379A (en) 19-nor-pregnene derivatives
GB9702194D0 (en) Sulphonide derivatives
IL125226A0 (en) Heterocycle-condensed morphinoid derivatives (II)
HUP9902993A3 (en) Alkylaminobenzothiazole and -benzoxazole derivatives
HUP9701835A3 (en) Vinyl-pirrolidinone-cephalosporin derivatives
IL129418A0 (en) 2-Methoxyphenylpiperazine derivatives
IL125149A0 (en) Pyrazol-4-yl-hetaroyl derivatives
PL334558A1 (en) Cephalosporinic derivatives
HU9701479D0 (en) N-benzylazolium derivatives
GB2321457B (en) 5-Aroylnaphthalene derivatives
ZA972051B (en) Benzodiazonine derivatives
GB9701628D0 (en) Imino-aza-anthracyclinone derivatives
GB9600063D0 (en) Guaridine derivatives
GB9603226D0 (en) Heterocyclyl-ergoline derivatives
ZA971911B (en) 2-thioxo-tetrahydropyrimidin-4-one derivatives
IL130283A0 (en) Polysaccharide-peptide derivatives
GB9702049D0 (en) Tetrahhydroisoquinoline derivatives
HU9601036D0 (en) Aryl-sulfonyl-hydroxamic-acid derivatives
GB9706753D0 (en) Aralkoxy-morphinan derivatives
ZA971502B (en) Pyrazol-4-yl-hetaroyl derivatives
ZA972808B (en) aminodihydropyridine derivatives